Your Specialized CRO
Bringing a product to market requires therapeutic specialization, scientific expertise, a proactive, solutions-driven mindset, and open communication. It requires the Symbio touch.
Symbio offers end-to-end clinical trial solutions made for dermatology, aesthetics, gastroenterology, and inflammation drug and device development globally.
As true therapeutic specialists, we provide integral insights that optimize each layer, from skin to system and early phase to postmarket.
70+ FDA Approvals | 650+ Trials | 85+ Indications
End-to-End Specialty CRO Services
Unlike with large, generalist CROs, our focused, responsive team becomes your true partner for Phase I-IV global trial delivery, tailoring solutions to your specific therapeutic area and bringing your product to market faster and with greater confidence.
- Clinical Trial Project Management
- Clinical Trial Site Feasibility and Startup
- Clinical Trial Monitoring
- Medical Monitoring
- Regulatory Affairs
- Medical Writing Services
- Clinical Data Management
- Biostatistics Services
- Topical Formulation Development
▶
2x Faster Startup Than Industry Standards
▶
<8% Average Screen Fail Rate
▶
70% Average Patient Retention
The Symbio Promise
When you choose Symbio as your specialty CRO, you’re choosing a therapeutically focused, experienced partner that aligns with your goals and adapts to your needs with the same flexible team from start to finish — no handoffs, no turnover, just seamless continuity.
Because when expertise and collaboration come together, they create a ripple of confidence that is felt all the way to the patient.
Global Reach
Our global clinical trial capabilities and network across North America, Europe, Australia, and subsidiaries around the globe support you from step one to final approval.